Potential for testing therapies
Author: Editor
New HSP genotypes & phenotypes
Research from China, Mali, India, Taiwan, Russia, Saudi Arabia
Gene therapy access and affordability
Addressing the challenge globally
Kurt Fearnley appointed NDIA Chair
Disabilty advocate Graeme Innes on the board
NDIS update
Concerns Robo-debt coming to NDIS
Progress on HSP gene therapies
SPG4 and SPG56 research
Community member socials
Held in Victoria, Qld, NSW & ACT
Annual General Meeting
Committee elections
Disability Royal Commission
Heartbreaking evidence heard
Gene therapy development for AP-4 HSPs
Manufacturing collaboration announced